Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder.
about
The adult psychiatrist's dilemma: psychostimulant use in attention deficit/hyperactivity disorderInfluence of methylphenidate on brain development--an update of recent animal experiments.Treatment of adults with attention-deficit/hyperactivity disorderTreatment of adults with attention-deficit/hyperactivity disorderImaging genetics in attention-deficit/hyperactivity disorder and related neurodevelopmental domains: state of the art.Thalamo-cortical dysfunction in cocaine abusers: implications in attention and perception.Convergent pharmacological mechanisms in impulsivity and addiction: insights from rodent models.Prenatal exposure to methylphenidate affects the dopamine system and the reactivity to natural reward in adulthood in rats.What have positron emission tomography and 'Zippy' told us about the neuropharmacology of drug addiction?Dissociable effects of monoamine reuptake inhibitors on distinct forms of impulsive behavior in rats.Abnormal behaviors and microstructural changes in white matter of juvenile mice repeatedly exposed to amphetamine.Improvement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson's diseaseEvidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology.Environmental enrichment has no effect on the development of dopaminergic and GABAergic fibers during methylphenidate treatment of early traumatized gerbils.Substance use disorders in children and adolescents with attention-deficit/hyperactivity disorder: implications for treatment and the role of the primary care physician.Methylphenidate disrupts social play behavior in adolescent ratsDrug use related problems among nonmedical users of prescription stimulants: a web-based survey of college students from a Midwestern university.Osmotic release oral system-methylphenidate improves neural activity during low reward processing in children and adolescents with attention-deficit/hyperactivity disorder.Discriminative stimulus and subject-rated effects of methamphetamine, d-amphetamine, methylphenidate, and triazolam in methamphetamine-trained humans.Animal model of methylphenidate's long-term memory-enhancing effects.Recent progress in neuroactive marine natural products.Guanfacine extended release as adjunctive therapy to psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder.The neurobiology of oppositional defiant disorder and conduct disorder: altered functioning in three mental domains.Exploring the relationship among ADHD, stimulants, and substance abuse.The use of lisdexamfetamine dimesylate for the treatment of ADHD and other psychiatric disorders.Dopamine Reuptake Inhibitors in Parkinson's Disease: A Review of Nonhuman Primate Studies and Clinical Trials.Total Synthesis (+)-7-Bromotrypargine and Unnatural Analogs: Biological Evaluation Uncovers Activity at CNS Targets of Therapeutic Relevance.Psychopharmacology of ADHD in pediatrics: current advances and issues.Amphetamine withdrawal differentially affects hippocampal and peripheral corticosterone levels in response to stress.Analysis of anonymous pooled urine from portable urinals in central London confirms the significant use of novel psychoactive substances.Changing Epidemiology of Methylphenidate Prescriptions in the Community: A Multifactorial Model.Withdrawal effect of chronic amphetamine exposure during adolescence on complex maze performance.Investigating the roles of different monoamine transmitters and impulse control using the 5-choice serial reaction time task.Methylphenidate and nicotine focus responding to an informative discrete CS over successive sessions of appetitive conditioning.Current issues and trends in the diagnosis and treatment of adults with ADHD.The Impact of Chronic Early Administration of Psychostimulants on Brain Expression of BDNF and Other Neuroplasticity-Relevant Proteins.Stimulant medications: a trade-off? The lived experience of adolescents with ADHD.Development of an LC-MS/MS method for the analysis of serotonin and related compounds in urine and the identification of a potential biomarker for attention deficit hyperactivity/hyperkinetic disorder.
P2860
Q22241830-83011591-8654-4A19-8707-5EE299577BD3Q24537917-593DEA9E-CD11-483F-BDC4-D8A9A8FF63E2Q24642937-B6681C17-01A4-46B6-9414-35249B7F32F1Q24644586-EBCED3E4-8A16-4169-9323-D2FAC867AC7CQ30240118-75964694-D786-4BF0-91FC-2D1AA2048571Q30496711-31D1278E-B88B-4D3C-ACD8-1B665E66725FQ34407185-547ACEF8-E2D6-476E-9583-B3BB829F42F6Q35179006-FEDE8E56-A680-48F6-A1A0-DFB483350C66Q35195505-794D2D6F-E7E9-476D-BCCC-C08FBAD3D5F6Q35644125-051694C8-1487-456F-AC16-4DB37CF3E5DDQ36168824-C65963D6-2EBE-49E6-AFAC-6BC8DD81407EQ36227392-2AFBDBE4-A1C3-4AE0-BABE-7D0022380548Q36648476-DF80A846-709F-4D9D-8415-BBB372801191Q36699305-80A29CE9-90F1-4ADD-976F-FDE4A29CFB66Q36746621-326A9FB6-D1ED-4870-9869-B41A0E4247B4Q36967270-A093B132-A8ED-4561-9CA5-40B1884A12ADQ37087802-DB3110E2-5439-4F23-A0D3-24911853545CQ37184589-5C0A6CA0-0063-40C0-A243-7875A63A127EQ37192699-9A0537F2-018B-4363-A94A-D5BECEBBD936Q37491483-4DAE249E-E63D-4AD1-868C-36CA27B48AAFQ37639029-E86DA372-6FC6-46CD-937E-1ED55C7150B8Q38011640-816B34AA-E8C1-4FFB-8B41-D954E4CCFFD3Q38026642-35F8DDB8-48FC-4437-97FF-B386A2AC6532Q38029373-C5C72B9F-2A2E-4648-831E-BEC070F670AFQ38221823-68D28243-5A5A-4238-979A-69D889BEA04FQ38837020-A4BCE6BA-041E-4D93-BEDD-409A57C6BB5EQ40256255-82CBFF4D-ADD3-44B3-B9FB-65938C2F838DQ41528514-A2B0EBAE-8FEE-48CF-85A6-D49B9B6B38A9Q42540788-A323C946-F203-4BA4-90C9-D4D16B3909FBQ43351980-D70CC10F-C22C-49DF-B4C9-FDFDF8904906Q44510122-9028DFE2-347E-4DED-9BD2-9A817BA4B8D0Q44768645-55D5203A-2D1E-4C55-8E89-F748827B7DE8Q46649081-211564D3-065F-4869-8971-8FE76BBC4490Q46798702-AB4A2E2A-39AF-4294-8DB2-A50CA0AED22CQ46947976-D3D91DF9-E188-4211-9319-22249C1A8504Q47679266-8D388E15-8570-4303-A9A5-D1BF591C0CADQ48430394-2F2F6973-8CC7-494F-B1BD-B5A7366E3CF2Q48933564-58E48CBC-0768-4DD3-8CFA-A3A05E3C71CA
P2860
Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder.
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder.
@ast
Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder.
@en
Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder.
@nl
type
label
Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder.
@ast
Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder.
@en
Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder.
@nl
prefLabel
Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder.
@ast
Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder.
@en
Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder.
@nl
P1476
Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder.
@en
P2093
Kevin C F Fone
P356
10.1016/J.COPH.2004.10.001
P50
P577
2005-02-01T00:00:00Z